|
To learn more about SeaGen's groundbreaking data, click here.
• Astellas Pharma Support Solutions
• MyNavCare Patient Support By Genmab
• Lilly Oncology Support Center Details >
• Revised Policies / Articles
• Proposed LCDs Are Open For Comment
• Proposed LCD Open Meeting Details >• Enroll in EFT to Get Paid for CHAMPVA Claims
• G2211 Add-on Complexity
• Updated Medicare Hot Links
• And More Details >New training opportunities availableDetails >
Recent Oncology Related Articles• Medicare Two Dollar Drug List Model
• Cost Savings for 54 Prescription Drugs
• Clinical Laboratory Fee Schedule
• MLN Matters
• And More Details >• New Links on the eCQI Resource Center
• 2024 MVPs Registration Open
• 2025 Virtual Group Election Period Now Open
• 2024 Qualifying APM Participant (QP) Status Details >• Advanced APM Incentive Payment
• New APM and APP Resources Details >This edition includes articles on• Don’t use the Neoplasm Table with NETs
• 340 B Drugs: Rebates Versus Discounts
• MDRP Final Rule Unveiled
• Discharge Summaries Make a Difference Details >
Recent Oncology Related News• Provider Portal Feature to Enhance Prior Auth Process
• Guidelines for Billing Split or Shared Visits
• Oncology Medical Drug Management Moving to OncoHealth Details >Publications• The Record
• BCN Provider News Details >
Last Reviewed/Updated 10-15-24• BCBSM Below Cost Reimbursement
• 0885 Claims Denied
• Procrit Denials (693)
• Procrit or Epoetin Class Drugs Maintenance
• And More Details >Last Reviewed/Updated 10-15-24• BCBSM Carelon Letter Details >• Prior Auth Requirements, Benefit Coverage Updates, & Pharmacy Infor
• Medicare Complete Duals Annual Required Training
• Keep Provider Information Updated in NPPES Details >• Oct. 29 2025 DBM Program
• Drug Take Back Day Oct. 26
• Understanding Why a Claim is Denied
• Exclusion Criteria Added to SUPD Provider Tipsheet
• And More Details >• Reimbursement Policy Updates
• Medical Policy Updates
• PharmacyUpdate
• Clinical Program Drug Strp Therapy
• And More Details >
• Johnson & Johnson Rybrevant (amivantamab-vmjw)
• Sanofi Sarclisa (isatuximab)
• AstraZeneca Tagrisso (osimertinib)
• Pfizer Hympavzi (marstacimab-hncq) Details > • BeiGene's TEVIMBRA® (tislelizumab-jsgr) Injection Receives J-code & WAC
• NTAP Available for Johnson & Johnson's TALVEY® (talquetamab-tgvs)
• Results of Aveo's Phase 3 TiNivo-2 Study Details >
October 2024 Frequently Asked Questions• Codes 96372 & 96373
• ASP Pricing Files
• HCPCS Code or Drug Not Found on ASP Pricing Files
• Recently Approved Generic Drug Details > |
